Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

Take a good look at Cassava Sciences SAVA story. RLFTF will rebound like SAVA did.

Sava got a bad report from the FDA and sank to 2.57 a share. Than the FDA, months later, reported great news and sava hit a high 146.00 a share. Looking good, right,? Than a bad actor investment firm reports that the study results were a lie. sava goes down again. months later, the bad actor was found to be wrong. the results were good. Sava rebounds back to a high of 76.00.

The FDA and bad actors are common trouble for pharma, especially small pharma.

Study sava and hold your shares.

~ Fred, Y@h00 RLFTF finance conversations